Similar articles

• Clinical cases and problems of delayed (tardive) reactions to drugs--for pharmaceuticals in general.

  Hama R. Hama R. J Toxicol Sci. 1996 Feb;21(1):81-91. doi: 10.2131/jts.21.81. J Toxicol Sci. 1996. PMID: 8852293 Review. No abstract available.
• [Drug hypersensitivity: definitions and mechanisms].

  Villani A, Demoly P, Nicolas JF. Villani A, et al. Rev Prat. 2015 Sep;65(7):969-71. Rev Prat. 2015. PMID: 26619737 French. No abstract available.
• How to predict adverse immune reactions induced by pharmaceutical compounds.

  Goldman M, Miller K, Bazin H. Goldman M, et al. Trends Biotechnol. 1995 Aug;13(8):283-5. doi: 10.1016/S0167-7799(00)88965-9. Trends Biotechnol. 1995. PMID: 7662302 No abstract available.
• Immunogenicity of biopharmaceuticals in laboratory animals.

  Wierda D, Smith HW, Zwickl CM. Wierda D, et al. Toxicology. 2001 Feb 2;158(1-2):71-4. doi: 10.1016/s0300-483x(00)00410-8. Toxicology. 2001. PMID: 11164995 Review.
• Prediction of adverse drug reactions using decision tree modeling.

  Hammann F, Gutmann H, Vogt N, Helma C, Drewe J. Hammann F, et al. Clin Pharmacol Ther. 2010 Jul;88(1):52-9. doi: 10.1038/clpt.2009.248. Epub 2010 Mar 10. Clin Pharmacol Ther. 2010. PMID: 20220749